Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenomics in Asians: Differences and similarities with other human populations
Mohitosh Biswas, Pimonpan Jinda, Chonlaphat Sukasem
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 1, pp. 27-41
Closed Access | Times Cited: 17

Showing 17 citing articles:

The association of CYP2C19LoF alleles with adverse clinical outcomes in stroke patients taking clopidogrel: An updated meta‐analysis
Mohitosh Biswas, Md. Shahadat Hossain, Tahsin Ahmed Rupok, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 6
Pharmacogenomics and non-genetic factors affecting drug response in autism spectrum disorder in Thai and other populations: current evidence and future implications
Mohitosh Biswas, Natchaya Vanwong, Chonlaphat Sukasem
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Vitamin D Status, VDR, and TLR Polymorphisms and Pulmonary Tuberculosis Epidemiology in Kazakhstan
Dauren Yerezhepov, Aidana Gabdulkayum, Ainur Akhmetova, et al.
Nutrients (2024) Vol. 16, Iss. 4, pp. 558-558
Open Access | Times Cited: 4
Integration of LC–MS-based untargeted and targeted metabolomics to uncover novel whole-grain wheat dietary intake biomarkers in the plasma of the Chinese population
Yunjia Yang, Yalin Zhou, W.Z. Ye, et al.
Food Research International (2025) Vol. 202, pp. 115740-115740
Closed Access
Implementation of pre‐emptive testing of a pharmacogenomic panel in clinical practice: Where do we stand?
Elena Peruzzi, Rossana Roncato, Elena De Mattia, et al.
British Journal of Clinical Pharmacology (2023)
Open Access | Times Cited: 8
Molecular identification of HLA‐B75 serotype markers by qPCR: A more inclusive pharmacogenetic approach before carbamazepine prescription
Kanoot Jaruthamsophon, Pornsiri Sangmanee, Oradawan Plong-On, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 6
Open Access | Times Cited: 2
Epidemiological and genetic aspects of pulmonary tuberculosis in Kazakhstan
Dauren Yerezhepov, Aidana Gabdulkayum, Ainur Akhmetova, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 10, pp. 102540-102540
Open Access | Times Cited: 2
Clinical Pharmacogenomics Implementation In Thailand: A Dream Come True
Chonlaphat Sukasem, Mohitosh Biswas, Palita Lungchukiet, et al.
Pharmacogenomics (2023) Vol. 24, Iss. 6, pp. 297-301
Closed Access | Times Cited: 6
Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design
Simone Birocchi, Matteo Rocchetti, Alessandro Minardi, et al.
Thrombosis and Haemostasis (2023) Vol. 124, Iss. 05, pp. 482-496
Closed Access | Times Cited: 6
Azole antifungals and inter-individual differences in drug metabolism: the role of pharmacogenomics and precision medicine
Mohitosh Biswas, Shobana John, Pimonpan Jinda, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 3, pp. 165-174
Closed Access | Times Cited: 5
Ethnic differences in pharmacogenomic variants: a south Asian perspective
Bani Jolly, Vinod Scaria
Pharmacogenomics (2024) Vol. 25, Iss. 4, pp. 171-174
Closed Access | Times Cited: 1
Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway Inhibitors
Yuya Yoshida, Masanobu Takahashi, Keigo Komine, et al.
Internal Medicine (2024)
Open Access | Times Cited: 1
Guided antiplatelet therapy with P2Y12 antagonists in patients undergoing percutaneous coronary intervention: 3 systematic reviews with meta-analyses of randomized controlled trials with homogeneous design
Simone Birocchi, Matteo Rocchetti, Alessandro Minardi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Pharmacogenomics of Chloroquine and Hydroxychloroquine: Current Evidence and Future Implications
Mohitosh Biswas, Chonlaphat Sukasem
Pharmacogenomics (2023) Vol. 24, Iss. 15, pp. 831-840
Closed Access | Times Cited: 2
CYP2C19 loss-of-function variants are independent risk factors for premature cerebral infarction: a hospital based retrospective study
Yuliang Shi, Yuxian Yang, Miaoling Feng, et al.
BMC Cardiovascular Disorders (2024) Vol. 24, Iss. 1
Open Access
Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention
Marco Cattaneo, Alessandro Squizzato, Simone Birocchi, et al.
Thrombosis and Haemostasis (2023) Vol. 124, Iss. 06, pp. 595-597
Closed Access
Insights into the population pharmacokinetics and pharmacodynamics of quetiapine: a systematic review
Han Lü, J.-N. Gu, Juehui Mao, et al.
Expert Review of Clinical Pharmacology (2023) Vol. 17, Iss. 1, pp. 57-72
Open Access
Page 1

Scroll to top